Study indicates lockdown significantly reduced coronavirus by Selina McKee | Jul 15, 2020 | News | 0 The findings provide a baseline for further research into how the virus is spreading in England Read More
Imperial and Bayer to use AI for heart conditions by Anna Smith | Dec 21, 2018 | News | 0 Researchers at Imperial and Bayer Pharmaceuticals are partnering up to explore how artificial intelligence (AI) can be used to accelerate the discovery of new drugs for heart conditions. Read More
Lilly streams £5m into virtual lab pact with UCL, Imperial by Selina McKee | Sep 7, 2018 | News | 0 Imperial College London, UCL and Eli Lilly have formed an alliance that strives to transform medicines manufacturing in England. Read More